StocksFundsScreenerSectorsWatchlists
BLCO

BLCO - Bausch + Lomb Corporation Stock Price, Fair Value and News

14.23USD-0.77 (-5.13%)Market Closed

Market Summary

BLCO
USD14.23-0.77
Market Closed
-5.13%

BLCO Stock Price

View Fullscreen

BLCO RSI Chart

BLCO Valuation

Market Cap

5.0B

Price/Earnings (Trailing)

-19.21

Price/Sales (Trailing)

1.2

EV/EBITDA

18.43

Price/Free Cashflow

-25.23

BLCO Price/Sales (Trailing)

BLCO Profitability

EBT Margin

-4.00%

Return on Equity

-3.8%

Return on Assets

-1.93%

Free Cashflow Yield

-3.96%

BLCO Fundamentals

BLCO Revenue

Revenue (TTM)

4.1B

Rev. Growth (Yr)

17.77%

Rev. Growth (Qtr)

16.48%

BLCO Earnings

Earnings (TTM)

-260.0M

Earnings Growth (Yr)

-5.3K%

Earnings Growth (Qtr)

35.71%

Breaking Down BLCO Revenue

Last 7 days

-13.5%

Last 30 days

-12%

Last 90 days

-6.5%

Trailing 12 Months

-12.7%

How does BLCO drawdown profile look like?

BLCO Financial Health

Current Ratio

1.74

Debt/Equity

0.66

Debt/Cashflow

0

BLCO Investor Care

Shares Dilution (1Y)

0.28%

Diluted EPS (TTM)

-0.74

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20233.8B3.9B4.0B4.1B
20223.8B3.8B3.8B3.8B
20213.5B3.6B3.7B3.8B
20200003.4B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Bausch + Lomb Corporation

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 29, 2024
robertson russel c
acquired
25,621
17.3
1,481
-
Mar 29, 2024
paulson john
acquired
21,867
17.3
1,264
-
Mar 29, 2024
de schutter richard u
acquired
26,866
17.3
1,553
-
Mar 05, 2024
ling karen
acquired
-
-
2,642
-
Mar 01, 2024
bonnefoy luc
sold (taxes)
-18,084
16.47
-1,098
president,surgical
Mar 01, 2024
hashad yehia
sold (taxes)
-35,295
16.47
-2,143
evp of r&d and cmo
Mar 01, 2024
munsch frederick
sold (taxes)
-16,387
16.47
-995
svp, controller and cao
Mar 01, 2024
eldessouky sam
sold (taxes)
-79,945
16.47
-4,854
evp and cfo
Feb 28, 2024
saunders brent l
acquired
-
-
187,919
ceo and chair
Feb 28, 2024
munsch frederick
acquired
-
-
18,183
svp, controller and cao

1–10 of 50

Which funds bought or sold BLCO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 09, 2024
Renaissance Capital LLC
added
2.99
16,952
399,215
0.21%
Apr 05, 2024
CWM, LLC
unchanged
-
-
3,000
-%
Mar 27, 2024
NOMURA HOLDINGS INC
unchanged
-
138,180
21,430,400
0.05%
Mar 22, 2024
PNC Financial Services Group, Inc.
sold off
-100
-25,968
-
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
new
-
2,390,820
2,390,820
-%
Feb 15, 2024
JANE STREET GROUP, LLC
added
1,887
8,909,690
9,378,630
-%
Feb 15, 2024
State of Wyoming
added
88.64
55,797
117,885
0.02%
Feb 15, 2024
BARCLAYS PLC
added
5,588
175,000
179,000
-%
Feb 14, 2024
MARSHALL WACE, LLP
new
-
1,377,680
1,377,680
-%
Feb 14, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
181,706
181,706
-%

1–10 of 40

Are Funds Buying or Selling BLCO?

Are funds buying BLCO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BLCO
No. of Funds

Unveiling Bausch + Lomb Corporation's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
bausch health companies inc.
88.7%
310,449,643
SC 13G

Recent SEC filings of Bausch + Lomb Corporation

View All Filings
Date Filed Form Type Document
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Mar 07, 2024
3
Insider Trading
Mar 07, 2024
4
Insider Trading
Mar 04, 2024
4
Insider Trading
Mar 04, 2024
4
Insider Trading
Mar 04, 2024
4
Insider Trading
Mar 04, 2024
4
Insider Trading
Mar 01, 2024
4
Insider Trading

Bausch + Lomb Corporation News

Latest updates
Yahoo Finance08 Apr 202403:40 pm
Simply Wall St25 Mar 202407:00 am
MarketWatch21 Feb 202408:00 am

Bausch + Lomb Corporation Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Revenue16.5%1,1731,0071,0359319969429418891,001949934881-
Costs and Expenses16.2%1,124967992933945896885835909855876796-
  S&GA Expenses15.6%483418417418386381368343365348358318-
EBITDA Margin-0.3%0.12*0.12*0.13*0.14*0.16*0.17*0.18*0.18*0.19*0.20*0.20*0.21*0.21*
Interest Expenses30.3%99.0076.0058.0050.0047.0035.0044.0020.00-----
Income Taxes-113.3%-6.0045.0010.0033.00-2.0034.0020.006.0032.0025.0021.0047.00-
Earnings Before Taxes-62.9%-57.00-35.00-19.00-55.00-2.0019.0027.0029.0086.0088.0067.0077.00-
EBT Margin-43.2%-0.04*-0.03*-0.01*0.00*0.02*0.04*0.06*0.07*0.08*0.08*0.08*0.08*0.08*
Net Income35.7%-54.00-84.00-32.00-90.00-1.00-18.005.0020.0051.0060.0044.0027.00-
Net Income Margin-20.2%-0.06*-0.05*-0.04*-0.03*0.00*0.02*0.04*0.05*0.05*0.00*-0.01*-0.01*-0.01*
Free Cashflow-560.0%-69.0015.00-51.00-93.00109-22.00122-39.00100232205143-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q4
Assets2.9%13,44213,06811,31511,16911,14410,69611,00210,90710,823
  Current Assets11.3%2,7422,4642,3152,1842,1371,8592,0011,7191,635
    Cash Equivalents-6.8%331355384346354297446190177
  Inventory36.3%1,028754699697628605606598572
  Net PPE8.3%1,3901,2841,2941,2961,3001,2221,2431,2251,225
  Goodwill19791.3%4,57523.004,5404,5224,5074,4154,4934,5534,586
Liabilities5.4%6,5226,1854,2854,1174,0433,9014,0313,6911,421
  Current Liabilities13.9%1,5791,3861,3251,2541,2961,1991,2731,0921,099
  Long Term Debt2.2%4,5324,4352,6042,5082,4112,4132,417--
    LT Debt, Current0%30.0030.0025.0025.0025.0025.0025.00--
    LT Debt, Non Current2.2%4,5324,4352,6042,5082,4112,4132,417--
Shareholder's Equity0.5%6,8506,8177,0307,0527,0336,7956,9717,2169,402
  Retained Earnings-27.0%-254-200-116-84.006.007.0025.0020.00-
  Additional Paid-In Capital0.2%8,3498,3348,3218,3058,2858,1088,0888,219-
Shares Outstanding0.0%351351351350350350350350350
Minority Interest6.1%70.0066.0072.0069.0068.0066.0075.0076.0073.00
Float---802---603--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Cashflow From Operations-68.7%15,00048,000-24,000-56,000159,00027,000156,0003,000162,000273,000250,000188,000-
  Share Based Compensation0%16,00016,00018,00024,00017,00018,00011,00016,00017,00016,00015,00014,000-
Cashflow From Investing92.8%-135,000-1,882,000-28,000-64,000-90,000-49,000-35,000-41,000-81,000-40,000-45,000-48,000-
Cashflow From Financing-95.3%86,0001,811,00090,00091,000-7,000-109,000145,00052,000-37,000-378,000-183,000-114,000-

BLCO Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues   
Total revenues$ 4,146$ 3,768$ 3,765
Expenses   
Selling, general and administrative (Note 3)1,7361,4781,389
Research and development (Note 3)324307271
Amortization of intangible assets240244292
Other expense, net741317
Total expenses4,0163,5613,436
Operating income130207329
Interest income1560
Interest expense (Note 3)(283)(146)0
Foreign exchange and other(28)6(11)
(Loss) income before provision for income taxes(166)73318
Provision for income taxes(82)(58)(125)
Net (loss) income(248)15193
Net income attributable to noncontrolling interest(12)(9)(11)
Net (loss) income attributable to Bausch + Lomb Corporation$ (260)$ 6$ 182
Basic (loss) income per share attributable to Bausch + Lomb Corporation (in usd per share)$ (0.74)$ 0.02$ 0.52
Diluted (loss) income per share attributable to Bausch + Lomb Corporation (in usd per share)$ (0.74)$ 0.02$ 0.52
Basic weighted-average common shares (in shares)350.5350.0350.0
Diluted weighted-average common shares (in shares)350.5350.2350.0
Product sales   
Revenues   
Total revenues$ 4,131$ 3,746$ 3,737
Expenses   
Cost of goods sold (excluding amortization and impairments of intangible assets) (Note 3) and Cost of other revenues1,6401,5111,458
Other revenues   
Revenues   
Total revenues152228
Expenses   
Cost of goods sold (excluding amortization and impairments of intangible assets) (Note 3) and Cost of other revenues$ 2$ 8$ 9

BLCO Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 331$ 354
Restricted cash326
Trade receivables, net (Note 3)839724
Inventories, net1,028628
Prepaid expenses and other current assets (Note 3)541405
Total current assets2,7422,137
Property, plant and equipment, net1,3901,300
Intangible assets, net3,5892,058
Goodwill4,5754,507
Deferred tax assets, net921927
Other non-current assets (Note 3)225215
Total assets13,44211,144
Current liabilities:  
Accounts payable (Note 3)522370
Accrued and other current liabilities1,027901
Current portion of long-term debt3025
Total current liabilities1,5791,296
Deferred tax liabilities, net147
Other non-current liabilities397329
Long-term debt4,5322,411
Total liabilities6,5224,043
Commitments and contingencies (Notes 20 and 21)
Equity  
Common shares, no par value, unlimited shares authorized, 350,913,804 and 350,000,749 issued and outstanding at December 31, 2023 and December 31, 2022, respectively00
Additional paid-in capital8,3498,285
Accumulated (deficit) earnings(254)6
Accumulated other comprehensive loss(1,245)(1,258)
Total Bausch + Lomb Corporation shareholders’ equity6,8507,033
Noncontrolling interest7068
Total equity6,9207,101
Total liabilities and equity$ 13,442$ 11,144
BLCO
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
 CEO
 WEBSITEbausch.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES13000

Bausch + Lomb Corporation Frequently Asked Questions


What is the ticker symbol for Bausch + Lomb Corporation? What does BLCO stand for in stocks?

BLCO is the stock ticker symbol of Bausch + Lomb Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bausch + Lomb Corporation (BLCO)?

As of Fri Apr 12 2024, market cap of Bausch + Lomb Corporation is 4.99 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BLCO stock?

You can check BLCO's fair value in chart for subscribers.

What is the fair value of BLCO stock?

You can check BLCO's fair value in chart for subscribers. The fair value of Bausch + Lomb Corporation is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Bausch + Lomb Corporation is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BLCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Bausch + Lomb Corporation a good stock to buy?

The fair value guage provides a quick view whether BLCO is over valued or under valued. Whether Bausch + Lomb Corporation is cheap or expensive depends on the assumptions which impact Bausch + Lomb Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BLCO.

What is Bausch + Lomb Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, BLCO's PE ratio (Price to Earnings) is -19.21 and Price to Sales (PS) ratio is 1.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BLCO PE ratio will change depending on the future growth rate expectations of investors.